Andrew N Dauber MD MMSc
Pediatric Growth Disorder Endocrinology
Chief of Endocrinology, Children's National Medical Center
Join to view full profile
111 Michigan AveWashington, DC 20010
Phone+1 202-476-2121
Fax+1 202-476-4095
Dr. Dauber is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Endocrinology, 2008 - 2011- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2004 - 2008
Harvard Medical SchoolClass of 2004
Certifications & Licensure
MD State Medical License 2024 - 2028
DC State Medical License 2018 - 2027
VA State Medical License 2020 - 2026
MA State Medical License 2006 - 2020
OH State Medical License 2014 - 2019
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Endocrinology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age
- Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency Start of enrollment: 2018 Feb 01
- Vosoritide for Selected Genetic Causes of Short Stature Start of enrollment: 2020 Aug 04
Publications & Presentations
PubMed
- A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia.Andrew Dauber, Ravi Savarirayan, Philippe M Campeau, Ricki S Carroll, Moira Cheung
NEJM Evidence. 2026-11-01 - Perceived Impact of Vosoritide on Health-Related Quality of Life in Children with Selected Genetic Causes of Short Stature: A Qualitative Study of Children and Caregiv...Raheem Seaforth, Niusha Shafaei, Kimberly Pitner, Margaret Cho, Beverly Romero
Hormone Research in Paediatrics. 2026-09-04 - Slipped Capital Femoral Epiphysis during Vosoritide Therapy for Short Stature: A Case Series.Roopa Kanakatti Shankar, Matthew E Oetgen, Benjamin D Martin, Niusha Shafaei, Kimberly Pitner
Hormone Research in Paediatrics. 2026-09-01
Journal Articles
- Gain-of-Function DNMT3A Mutations Cause Microcephalic Dwarfism and Hypermethylation of Polycomb-Regulated RegionsAndrew Dauber, MD, Nature
- DLK1 Is a Novel Link Between Reproduction and MetabolismAndrew Dauber, MD, The Journal of Clinical Endocrinology and Metabolism
- Insights and Implications of Genome Wide Association Studies of HeightAndrew Dauber, MD, The Journal of Clinical Endocrinology and Metabolism
Press Mentions
Andrew Dauber, MD, MMSc, Named Director of the Center for Precision Medicine and Genomics Research at Children's NationalJuly 1st, 2026
Encouraging Early Results for Vosoritide in Turner SyndromeMay 23rd, 2025- Breaking Barriers in Growth Disorder Treatment for FamiliesJanuary 14th, 2025
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: